Internal Medicine · Northport, AL
NPI
1306808845
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
952 Rose Dr
Northport, AL, 35476
Phone (205) 339-8282
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
4,165 services
Medicare patients, 2024
356
Average age 76
Drug cost, 2024
$1.9M
18,105 prescriptions
Company payments, 2025
$1,785
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen D Browne was code 36415 (venipuncture blood collection), 869 times for 324 patients. In total Stephen D Browne billed 4,165 services in 42 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 869 | 324 | $8.65 | $7,514 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 768 | 73 | $0.08 | $61.61 |
| 99214 Office E&M - Established | Office | 531 | 278 | $75.96 | $40K |
| 99232 Hospital E&M - Subsequent | Facility | 420 | 60 | $60.13 | $25K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 228 | 45 | $0.49 | $112 |
| 96372 Injection Administration | Office | 189 | 79 | $9.80 | $1,852 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 184 | 184 | $18.20 | $3,349 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 179 | 179 | $127.33 | $23K |
| G0008 Administration of influenza virus vaccine | Office | 83 | 83 | $29.46 | $2,445 |
| 90661 Vaccine Product | Office | 80 | 80 | $36.11 | $2,889 |
| 99238 Hospital Discharge Management | Facility | 75 | 54 | $61.04 | $4,578 |
| 99223 Hospital E&M - Initial | Facility | 67 | 51 | $126.87 | $8,500 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 66 | 29 | $0.30 | $19.66 |
| 93000 Electrocardiogram | Office | 63 | 60 | $8.37 | $527 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 48 | 39 | $215.35 | $10K |
By year: 2022 $160K for 5,214 services; 2023 $149K for 4,920 services; 2024 $144K for 4,165 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 869 | 324 | $8.65 | $7,514 |
| 82270 Immunoassay | 15 | 15 | $4.29 | $64.35 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen D Browne prescribed most often to Medicare patients was Levothyroxine Sodium, with 635 prescriptions and refills. In total Stephen D Browne wrote 18,105 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 635 | 1,613 | 165 | $10K |
| Atorvastatin Calcium Generic | 574 | 1,583 | 168 | $6,806 |
| Alprazolam Generic | 560 | 668 | 101 | $2,873 |
| Ezetimibe Generic | 558 | 1,614 | 197 | $18K |
| Gabapentin Generic | 520 | 818 | 110 | $7,889 |
| Prednisone Generic | 469 | 489 | 270 | $957 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 459 | 459 | 78 | $8,296 |
| Fenofibrate Generic | 416 | 1,188 | 132 | $13K |
| Pantoprazole Sodium Generic | 371 | 1,035 | 129 | $5,098 |
| Omeprazole Generic | 331 | 910 | 111 | $4,515 |
| Pravastatin Sodium Generic | 327 | 890 | 103 | $4,788 |
| Rosuvastatin Calcium Generic | 323 | 916 | 113 | $5,059 |
| Labetalol Hcl Generic | 301 | 745 | 94 | $10K |
| Potassium Chloride Generic | 292 | 665 | 100 | $6,300 |
| Furosemide Generic | 267 | 655 | 90 | $1,307 |
Brand drugs: 2,437 claims; generic drugs: 15,642 claims; opioid claims: 1,137.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen D Browne $1,785 ($1,785 in general payments such as food, travel and fees) from 22 companies. The largest payer was Pfizer Inc. with $266.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 14 | $266 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $203 |
| Lilly USA, LLC LLY | 10 | $180 |
| Amgen Inc. AMGN | 16 | $173 |
| Esperion Therapeutics, Inc. ESPR | 9 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $119 |
| Novo Nordisk Inc NVO | 5 | $84.82 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $80.8 |
| Abbvie Inc. ABBV | 4 | $75.51 |
| Ardelyx, Inc. ARDX | 3 | $73.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.